CALIFORNIA BANCORP (BCAL) Stock Fundamental Analysis
NASDAQ:BCAL - Nasdaq - US84252A1060 - Common Stock - Currency: USD
Taking everything into account, BCAL scores 4 out of 10 in our fundamental rating. BCAL was compared to 397 industry peers in the Banks industry. BCAL has a bad profitability rating. Also its financial health evaluation is rather negative. BCAL is growing strongly while it is still valued neutral. This is a good combination!
1. Profitability
1.1 Basic Checks
In the past year BCAL was profitable.
In the past year BCAL had a positive cash flow from operations.
1.2 Ratios
The Return On Assets of BCAL (0.44%) is worse than 79.09% of its industry peers.
Looking at the Return On Equity, with a value of 3.27%, BCAL is doing worse than 83.12% of the companies in the same industry.
BCAL's Return On Invested Capital of 1.83% is amongst the best of the industry. BCAL outperforms 99.24% of its industry peers.
BCAL had an Average Return On Invested Capital over the past 3 years of 1.52%. This is in line with the industry average of 2.64%.
The last Return On Invested Capital (1.83%) for BCAL is above the 3 year average (1.52%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.44% | ||
| ROE | 3.27% | ||
| ROIC | 1.83% |
ROA(3y)0.65%
ROA(5y)N/A
ROE(3y)5.41%
ROE(5y)N/A
ROIC(3y)1.52%
ROIC(5y)N/A
1.3 Margins
BCAL has a worse Profit Margin (8.47%) than 84.63% of its industry peers.
BCAL's Profit Margin has declined in the last couple of years.
BCAL has a better Operating Margin (51.92%) than 99.75% of its industry peers.
BCAL's Operating Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 51.92% | ||
| PM (TTM) | 8.47% | ||
| GM | N/A |
OM growth 3Y19.95%
OM growth 5YN/A
PM growth 3Y-42.04%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BCAL is destroying value.
BCAL has more shares outstanding than it did 1 year ago.
BCAL has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of -0.72, we must say that BCAL is in the distress zone and has some risk of bankruptcy.
BCAL has a better Altman-Z score (-0.72) than 98.99% of its industry peers.
BCAL has a debt to FCF ratio of 70.14. This is a negative value and a sign of low solvency as BCAL would need 70.14 years to pay back of all of its debts.
With a Debt to FCF ratio value of 70.14, BCAL is not doing good in the industry: 86.40% of the companies in the same industry are doing better.
BCAL has a Debt/Equity ratio of 6.42. This is a high value indicating a heavy dependency on external financing.
BCAL's Debt to Equity ratio of 6.42 is on the low side compared to the rest of the industry. BCAL is outperformed by 97.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 6.42 | ||
| Debt/FCF | 70.14 | ||
| Altman-Z | -0.72 |
ROIC/WACC0.5
WACC3.64%
2.3 Liquidity
A Current Ratio of 0.03 indicates that BCAL may have some problems paying its short term obligations.
BCAL has a better Current ratio (0.03) than 99.24% of its industry peers.
A Quick Ratio of 0.03 indicates that BCAL may have some problems paying its short term obligations.
BCAL has a better Quick ratio (0.03) than 99.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.03 | ||
| Quick Ratio | 0.03 |
3. Growth
3.1 Past
The earnings per share for BCAL have decreased strongly by -18.18% in the last year.
The earnings per share for BCAL have been decreasing by -28.36% on average. This is quite bad
The Revenue has grown by 63.83% in the past year. This is a very strong growth!
Measured over the past years, BCAL shows a very strong growth in Revenue. The Revenue has been growing by 37.61% on average per year.
EPS 1Y (TTM)-18.18%
EPS 3Y-28.36%
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)63.83%
Revenue growth 3Y37.61%
Revenue growth 5YN/A
Sales Q2Q%104.6%
3.2 Future
Based on estimates for the next years, BCAL will show a very strong growth in Earnings Per Share. The EPS will grow by 54.53% on average per year.
BCAL is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.93% yearly.
EPS Next Y139.72%
EPS Next 2Y54.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year39.39%
Revenue Next 2Y20.93%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 16.36, which indicates a correct valuation of BCAL.
Based on the Price/Earnings ratio, BCAL is valued a bit more expensive than 71.54% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.30. BCAL is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 9.29, the valuation of BCAL can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BCAL indicates a somewhat cheap valuation: BCAL is cheaper than 67.00% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of BCAL to the average of the S&P500 Index (21.76), we can say BCAL is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.36 | ||
| Fwd PE | 9.29 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BCAL is valued cheaply inside the industry as 99.50% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BCAL is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.79 | ||
| EV/EBITDA | 4.69 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BCAL's earnings are expected to grow with 54.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.12
PEG (5Y)N/A
EPS Next 2Y54.53%
EPS Next 3YN/A
5. Dividend
5.1 Amount
BCAL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
16.2
-0.2 (-1.22%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)
Earnings (Next)
Inst Owners56.98%
Inst Owner Change0%
Ins Owners24.22%
Ins Owner Change-0.08%
Market Cap525.04M
Analysts80
Price Target18.02 (11.23%)
Short Float %1.73%
Short Ratio3.62
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.54%
Min EPS beat(2)13.64%
Max EPS beat(2)27.45%
EPS beat(4)3
Avg EPS beat(4)8.04%
Min EPS beat(4)-96.35%
Max EPS beat(4)87.43%
EPS beat(8)3
Avg EPS beat(8)-1.15%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.46%
Min Revenue beat(2)-8.89%
Max Revenue beat(2)-2.03%
Revenue beat(4)0
Avg Revenue beat(4)-3.69%
Min Revenue beat(4)-8.89%
Max Revenue beat(4)-1.17%
Revenue beat(8)0
Avg Revenue beat(8)-4.98%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-11.67%
EPS NQ rev (1m)0.99%
EPS NQ rev (3m)-2.4%
EPS NY rev (1m)0%
EPS NY rev (3m)2.53%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.59%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.48%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.36 | ||
| Fwd PE | 9.29 | ||
| P/S | 2.56 | ||
| P/FCF | 10.79 | ||
| P/OCF | 10.67 | ||
| P/B | 0.99 | ||
| P/tB | 1.32 | ||
| EV/EBITDA | 4.69 |
EPS(TTM)0.99
EY6.11%
EPS(NY)1.74
Fwd EY10.76%
FCF(TTM)1.5
FCFY9.27%
OCF(TTM)1.52
OCFY9.37%
SpS6.32
BVpS16.4
TBVpS12.29
PEG (NY)0.12
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.44% | ||
| ROE | 3.27% | ||
| ROCE | 17.68% | ||
| ROIC | 1.83% | ||
| ROICexc | 1.87% | ||
| ROICexgc | 1.98% | ||
| OM | 51.92% | ||
| PM (TTM) | 8.47% | ||
| GM | N/A | ||
| FCFM | 23.75% |
ROA(3y)0.65%
ROA(5y)N/A
ROE(3y)5.41%
ROE(5y)N/A
ROIC(3y)1.52%
ROIC(5y)N/A
ROICexc(3y)1.54%
ROICexc(5y)N/A
ROICexgc(3y)1.61%
ROICexgc(5y)N/A
ROCE(3y)15.77%
ROCE(5y)N/A
ROICexcg growth 3Y37.36%
ROICexcg growth 5YN/A
ROICexc growth 3Y36.52%
ROICexc growth 5YN/A
OM growth 3Y19.95%
OM growth 5YN/A
PM growth 3Y-42.04%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.05
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 6.42 | ||
| Debt/FCF | 70.14 | ||
| Debt/EBITDA | 30.73 | ||
| Cap/Depr | 12.1% | ||
| Cap/Sales | 0.28% | ||
| Interest Coverage | 1.79 | ||
| Cash Conversion | 44.32% | ||
| Profit Quality | 280.41% | ||
| Current Ratio | 0.03 | ||
| Quick Ratio | 0.03 | ||
| Altman-Z | -0.72 |
F-Score4
WACC3.64%
ROIC/WACC0.5
Cap/Depr(3y)28.31%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.57%
Cap/Sales(5y)N/A
Profit Quality(3y)372.76%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.18%
EPS 3Y-28.36%
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y139.72%
EPS Next 2Y54.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)63.83%
Revenue growth 3Y37.61%
Revenue growth 5YN/A
Sales Q2Q%104.6%
Revenue Next Year39.39%
Revenue Next 2Y20.93%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y53.59%
EBIT growth 3Y65.06%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y42.47%
FCF growth 3Y40.59%
FCF growth 5YN/A
OCF growth 1Y40.59%
OCF growth 3Y36.79%
OCF growth 5YN/A